Victory Capital Management’s Avalo Therapeutics AVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-5
| Closed | -$8K | – | 2706 |
|
|
2022
Q2 | $8K | Hold |
5
| – | – | ﹤0.01% | 2664 |
|
|
2022
Q1 | $6K | Sell |
5
-1
| -17% | -$1.2K | ﹤0.01% | 2696 |
|
|
2021
Q4 | $27K | Buy |
6
+1
| +20% | +$4.5K | ﹤0.01% | 2674 |
|
|
2021
Q3 | $34K | Hold |
5
| – | – | ﹤0.01% | 2708 |
|
|
2021
Q2 | $48K | Hold |
5
| – | – | ﹤0.01% | 2665 |
|
|
2021
Q1 | $42K | Buy |
5
+1
| +25% | +$8.4K | ﹤0.01% | 2678 |
|
|
2020
Q4 | $32K | Hold |
4
| – | – | ﹤0.01% | 2482 |
|
|
2020
Q3 | $26K | Hold |
4
| – | – | ﹤0.01% | 2419 |
|
|
2020
Q2 | $31K | Sell |
4
-3
| -43% | -$23.3K | ﹤0.01% | 2422 |
|
|
2020
Q1 | $46K | Buy |
+7
| New | +$46K | ﹤0.01% | 2798 |
|
|
2019
Q4 | – | Sell |
-2
| Closed | -$21K | – | 2689 |
|
|
2019
Q3 | $21K | Buy |
+2
| New | +$21K | ﹤0.01% | 3022 |
|